| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/10/2003 | US20030068687 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/10/2003 | US20030068686 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 04/10/2003 | US20030068685 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 04/10/2003 | US20030068684 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/10/2003 | US20030068682 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
| 04/10/2003 | US20030068679 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of tumors |
| 04/10/2003 | US20030068678 WISP polypeptides and nucleic acids encoding same |
| 04/10/2003 | US20030068674 Method of producing a biosensor protein capable of regulating a fluorescence property of green fluorescent protein, and the biosensor protein produced by the method |
| 04/10/2003 | US20030068672 Nucleotide sequences coding polypeptide for use in the treatment of psychological, respiratory, cardiovascular and pain disorders |
| 04/10/2003 | US20030068654 Method for sex determination of mammalian offspring |
| 04/10/2003 | US20030068648 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/10/2003 | US20030068647 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of nervous system and cancer disorders |
| 04/10/2003 | US20030068640 Diagnosing vision defects in mammals; obtain tissue sample, extract nucleotide sequences, detect mutaion in tigr allele, presence of mutation indicates vision defects |
| 04/10/2003 | US20030068627 Nucleic acids, proteins, and antibodies |
| 04/10/2003 | US20030068623 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/10/2003 | US20030068616 Evaluating efficiency of drug treatment; obtain cell, transform cell, incubate with modulator, monitor protein activity, adjustment in protein activity indicates modulator |
| 04/10/2003 | US20030068337 Composition comprising tumor cells and extracts and method using thereof |
| 04/10/2003 | US20030068323 Hybrid compositions for intracellular targeting |
| 04/10/2003 | US20030068308 Intrasplenic encapsulated cell therapy |
| 04/10/2003 | US20030068306 Medium for expanding natural killer cells expressing the CD56+CD3- phenotype, comprising CellGro registered SCGM to which has been added interleukin-2 and anti CD3 antibodies |
| 04/10/2003 | US20030068305 Stem cell and dental pulp harvesting method and apparatus |
| 04/10/2003 | US20030067478 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/10/2003 | US20030066987 Biodegradable, electrically conducting polymer for tissue engineering applications |
| 04/10/2003 | US20030066295 Cryopreservation system with controlled dendritic freezing front velocity |
| 04/10/2003 | CA2463404A1 Fragements of heat shock proteins and their use |
| 04/10/2003 | CA2462802A1 Nutrient medium for maintaining neural cells in injured nervous system |
| 04/10/2003 | CA2462795A1 Secreted proteins |
| 04/10/2003 | CA2462790A1 Ul16 binding protein 4 |
| 04/10/2003 | CA2462644A1 Human and murine cytokine polypeptides |
| 04/10/2003 | CA2462641A1 Whole cell engineering using real-time metabolic flux analysis |
| 04/10/2003 | CA2462628A1 Restricted expression lentiviral vectors |
| 04/10/2003 | CA2462424A1 A novel g protein-coupled receptor, gave 10 |
| 04/10/2003 | CA2462113A1 Multi-chain eukaryotic display vectors and uses thereof |
| 04/10/2003 | CA2462077A1 Fluorescent proteins |
| 04/10/2003 | CA2461998A1 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/10/2003 | CA2461859A1 Methods of derivation and propagation of undifferentiated human embryonic stem (hes) cells on feeder-free matrices and human feeder layers |
| 04/10/2003 | CA2461715A1 Proliferation and differentiation of stem cells using extracellular matrix and other molecules |
| 04/10/2003 | CA2461292A1 Apo-2 ligand variants and uses thereof |
| 04/10/2003 | CA2461254A1 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 04/10/2003 | CA2460917A1 Human tissue factor antibodies |
| 04/10/2003 | CA2460916A1 Methods and compositions for modulating interleukin-21 receptor activity |
| 04/10/2003 | CA2460396A1 Isolated grp94 ligand binding domain polypeptide and nucleic acid encoding same, crystalline form of same, and screening methods employing same |
| 04/10/2003 | CA2460261A1 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 04/10/2003 | CA2460257A1 Methods for diagnosing and treating heart disease |
| 04/10/2003 | CA2455389A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/10/2003 | CA2455225A1 Novel proteins and nucleic acids encoding same |
| 04/10/2003 | CA2453804A1 Unique properties of stem cells |
| 04/09/2003 | EP1300471A1 Nutritional mixture and method for early identification and count of gram-negative organisms |
| 04/09/2003 | EP1300469A1 Expression of laccase from basidiomyctes in transgenic plants |
| 04/09/2003 | EP1300468A2 TRNA synthetase |
| 04/09/2003 | EP1300463A1 Isolated nucleic acid molecules encoding SSX family members and uses thereof |
| 04/09/2003 | EP1300419A1 Antibody of human origin for inhibiting thrombocyte aggregation |
| 04/09/2003 | EP1300156A2 Otitis media vaccine |
| 04/09/2003 | EP1299556A2 Host cells containing multiple integrating vectors |
| 04/09/2003 | EP1299554A1 Dna sequences coding for a polyol carrier and use thereof, in particular for preparing transgenic plants |
| 04/09/2003 | EP1299553A2 Modification of gene expression in transgenic plants |
| 04/09/2003 | EP1299547A1 Lipoxygenase genes, promoters, transit peptides and proteins thereof |
| 04/09/2003 | EP1299546A2 Aminoacyl trna synthetases |
| 04/09/2003 | EP1299545A2 Drug metabolizing enzymes |
| 04/09/2003 | EP1299544A2 Fimh adhesin proteins and methods of use |
| 04/09/2003 | EP1299540A2 Mutations of cryptic splice sites in cre and cre fused proteins for improvement of expression and inducibility |
| 04/09/2003 | EP1299538A2 Secreted proteins |
| 04/09/2003 | EP1299535A2 Peptide extended glycosylated polypeptides |
| 04/09/2003 | EP1299534A2 Grf2-binding proteins and applications thereof |
| 04/09/2003 | EP1299530A2 Novel compounds |
| 04/09/2003 | EP1299529A2 Conserved diaphanous-related formin autoregulatory domain (dad) |
| 04/09/2003 | EP1299528A1 Human olfactory receptors and genes encoding same |
| 04/09/2003 | EP1299524A1 Human myeloma cell line |
| 04/09/2003 | EP1299522A2 Alteration of cell membrane |
| 04/09/2003 | EP1299417A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 04/09/2003 | EP1299416A2 Antifungal and/or antibacterial peptides, preparation methods and composition containing same |
| 04/09/2003 | EP1299414A2 Fluorescent proteins |
| 04/09/2003 | EP1299412A2 Protein modification and maintenance molecules |
| 04/09/2003 | EP1299410A2 GFR alpha1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 04/09/2003 | EP1299407A2 Maize glutamine synthetase gene promoter |
| 04/09/2003 | EP1299385A2 Fused cyclic modulators of nuclear hormone receptor function |
| 04/09/2003 | EP1299113A2 Use of the heat shock protein gp96 |
| 04/09/2003 | EP1299032A1 DNA encoding human serine protease D-G |
| 04/09/2003 | EP1298991A2 High purity x-chromosome bearing and y-chromosome bearing populations of spermatozoa |
| 04/09/2003 | EP1230342A4 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 04/09/2003 | EP1077599A4 PARTICLE BOMBARDMENT TRANSFORMATION OF $i(BRASSICA) |
| 04/09/2003 | EP1034255A4 Lineage restricted glial precursors from the central nervous system |
| 04/09/2003 | EP0912191B1 Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine |
| 04/09/2003 | EP0804552B1 Redirection of cellular immunity by receptor chimeras |
| 04/09/2003 | EP0795608B1 Antithrombotic agent and anti-von willebrand factor monoclonal antibodies |
| 04/09/2003 | EP0784685B1 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor |
| 04/09/2003 | EP0723455B1 Method of inhibiting phagocytosis |
| 04/09/2003 | EP0722462B1 Dna encoding prostaglandin receptor ip |
| 04/09/2003 | EP0708831B1 Cell-density enhanced protein tyrosine phosphatases |
| 04/09/2003 | EP0675956B1 New protein from urine named component b |
| 04/09/2003 | EP0482053B1 Methode for inhibiting ethylene production in plants |
| 04/09/2003 | CN2543962Y 反应器 Reactor |
| 04/09/2003 | CN1409767A Recombinant sendai virus vector for introducing exogenous gene to airway epithelia |
| 04/09/2003 | CN1409766A 转基因昆虫 GM insects |
| 04/09/2003 | CN1409764A Pseudomonas aeruginosa antigens |
| 04/09/2003 | CN1409762A Promoter and intron from maize actin depolymerizing factor |
| 04/09/2003 | CN1409759A Compositions and methods for halogenation reactions |
| 04/09/2003 | CN1409758A Stabilizing diluent for polypeptides and antigens |
| 04/09/2003 | CN1409726A Type I cytokine receptor TCCR |
| 04/09/2003 | CN1409722A Antagonists of BMP and TGF beta signalling pathway |